Contribution of human hepatic cytochrome P450s and steroidogenic CYP17 to the N-demethylation of aminopyrine

Xenobiotica

Volumn 29, Issue 2, 1999, Pages 187-193

  Niwa, T ^a,c   Sato, R ^a   Yabusaki, Y ^b   Ishibashi, F ^a   Katagiri, M ^a  

^a OSAKA KYOIKU UNIVERSITY   (Japan)

^b SUMITOMO CHEMICAL CO LTD   (Japan)

^c Fujsawa Pharmaceutical Co   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENAZONE; AMINOPYRINE N DEMETHYLASE; CYTOCHROME B5; CYTOCHROME P450; MAGNESIUM ION;

ARTICLE; CONTROLLED STUDY; DEMETHYLATION; ENZYME ACTIVITY; ESCHERICHIA COLI; HUMAN; MICHAELIS MENTEN KINETICS; NONHUMAN; SACCHAROMYCES CEREVISIAE; STEROIDOGENESIS;

ESCHERICHIA COLI; SACCHAROMYCES CEREVISIAE;

EID: 0032934859     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599238731     Document Type: Article

References (25)

1. AGUNDEZ, J. A. G., CARRILLO, J. A., MARTINES, C. and BENIDEZ, J., 1995a, Aminopyrine metabolism in man: the acetylation of aminoantipyrine cosegregates with acetylation of caffeine. Therapeutic Drug Monitoring, 17, 1-5.
2. AGUNDEZ, J. A. G., MARTINES, C. and BENIDEZ, J., 1995b, Metabolism of aminopyrine and derivatives in man: in vivo study of monomorphic and polymorphic metabolic pathway. Xenobiotica, 25, 417-427.
3. AOYAMA, T., KORZEKWA, K., NAGATA, K., GILLETTE, J., GELBOIN, H. V. and GONZALEZ, F. J., 1990, Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome P450s. Endocrinology, 126, 3101-3106.
4. FUNAE, Y. and IMAOKA, S., 1993, Cytochrome P450 in rodents. In J. B. Schenkman and H. Greim (eds), Cytochrome P450 (Berlin: Springer), pp. 221-238.
5. GARCIA-AGUNDEZ, J. A. G., LURNGO, A., BENITEZ, J. and BENIDEZ, J., 1990, Aminopyrine N-demethylase activity in human liver microsomes. Clinical and Pharmacological Therapeutics, 48, 490-495.
6. GUENGERICH, F. P., 1992, Characterization of human cytochrome P450 enzymes. FASEB Journal, 6, 745-748.
7. GUENGERICH, F. P., 1996, In vitro techniques for studying drug metabolism. Journal of Pharmacokinetics and Biopharmaceutics, 24, 521-533.
8. GUENGERICH, F. P., GILLAM, M. J. and SHIMADA, T., 1996, New applications of bacterial systems to problems in toxicology. Critical Review in Toxicology, 26, 551-583.
9. IMAI, T., GLOBERMAN, H., GERTNER, J. M., KAGAWA, N. and WATERMAN, M. R., 1993, Expression and purification of functional human 17α-hydroxylase/17,20-lyase (P450c17) in Escherichia coli: use of this system for study of a novel form of combined 17α-hydroxylase/17,20-lyase deficiency. Journal of Biological Chemistry, 268, 10681-10689.
10. IMAOKA, S., YAMADA, T., HIROI, T., HAYASHI, K., SAKAKI, T., YABUSAKI, Y. and FUNAE, Y., 1996, Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Biochemical Pharmacology, 51, 1041-1050.
11. INOUE, K., YAMAZAKI, H., IMIYA, K., AKASAKA, S., GUENGERICH, F. P. and SHIMADA, T., 1997, Relationship between CYP2C9 and CYP2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations. Pharmacogenetics, 7, 103-113.
12. KAGAWA, N. and WATERMAN, M. R., 1995, Regulation of steroidogenic and related P450s. In P. R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd edn (New York: Plenum), pp. 419-442.
13. 5 in the biosynthesis of androgens by human P450c17. Archives of Biochemistry and Biophysics, 317, 343-347.
14. KOMORI, M., HASHIZUME, T., OHI, H., MIURA, T., KITADA, M., NASHIMA, K. and KAMATAKI, T., 1988, Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. Journal of Biochemistry, 104, 912-916.
15. MOFFAT, J., 1986, Dypirone-containing analgesica. South African Medical Journal, 70, 331-332.
16. NASH, T., 1953, The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemical Journal, 55, 416-421.
17. NIWA, T., NARITOMI, Y., KAWANO, M., UEDA-SHIMOHIRA, Y., TAKESHITA, K., SHIRAGA, T., IWASAKI, K. and NODA, K., 1994, Effect of repeated injection of somatomedin C on drug metabolizing enzyme activities in rats. Research Communications in Chemical Pathology and Pharmacology, 83, 341-348.
18. NIWA, T., YABUSAKI, Y., HONMA, K., MATSUO, N., TATSUTA, K., ISHIBASHI, F. and KATAGIRI, M., 1998, Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica, 28, 539-547.
19. NORKUS, E. P. and KUENZIG, W. A., 1985, Studies on the antimutagenic activity of ascorbic acid in vitro and in vivo. Carcinogenesis, 6, 1593-1598.
20. OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry, 239, 2370-2378.
21. PISCIOTTA, A. V., 1990, Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leucocytes and their marrow precursors. Blood Reviews, 4, 226-237.
22. SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414-423.
23. SHIRAGA, T., IWASAKI, K., NOZAKI, K., TAMURA, T., YAMAZOE, Y., KATO, R. and TAKANAKA, A., 1994, Isolation and characterization of four cytochrome P450 isozymes from untreated and pheno-barbital-treated beagle dogs. Biological and Pharmaceutical Bulletin, 17, 22-28.
24. VOLZ, M. and KELLNER, H.-M., 1980, Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine, and dipyrone). British Journal of Clinical Pharmacology, 10, 299S-308S.
25. WILKINSON, G. R., GUENGERICH, F. P. and BRANCH, R. A. 1989, Genetic polymorphism of S-mephenytoin hydroxylation. Pharmacology and Therapeutics, 43, 53-76.